Literature DB >> 3409022

Direct catecholaminergic projection from nucleus tractus solitarii to supraoptic nucleus.

T A Day1, J R Sibbald.   

Abstract

To determine whether the supraoptic nucleus (SON) receives a direct projection from catecholamine cells of the nucleus tractus solitarii (NTS), retrograde transport of rhodamine-tagged latex microspheres was combined with a procedure for the fluorescence histochemical visualization of catecholamines. SON tracer injections, made via transpharyngeal approach, retrogradely labelled cells at all levels of NTS, although the majority were located caudal to obex with an ipsilateral predominance. Approximately half of these cells were also identified as catecholaminergic; the relatively caudal level in the dorsomedial medulla of most of these cells suggests that they probably correspond to the A2 catecholamine cell group.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3409022     DOI: 10.1016/0006-8993(88)90843-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  4 in total

1.  The Physiological Society proceeding of the scientific meeting held at University of Edinburgh, 2-6 July 1996. Abstracts.

Authors: 
Journal:  J Physiol       Date:  1996-09       Impact factor: 5.182

2.  Involvement of cholecystokinin receptor types in pathways controlling oxytocin secretion.

Authors:  S M Luckman; M Hamamura; I Antonijevic; S Dye; G Leng
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

3.  Noradrenergic excitation of magnocellular neurons in the rat hypothalamic paraventricular nucleus via intranuclear glutamatergic circuits.

Authors:  S S Daftary; C Boudaba; K Szabó; J G Tasker
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

4.  Presynaptic actions of morphine: blockade of cholecystokinin-induced noradrenaline release in the rat supraoptic nucleus.

Authors:  T Onaka; S M Luckman; R Guevara-Guzman; Y Ueta; K Kendrick; G Leng
Journal:  J Physiol       Date:  1995-01-01       Impact factor: 5.182

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.